The team that studied the coronavirus in veterans found no positive effect from hydroxychloroquine
There was a specific reason for President Trump’s sudden announcement on Monday that he was taking the antimalarial drug hydroxychloroquine. His goal was to undermine a whistleblower who had raised questions about the administration’s handling of the coronavirus pandemic, a whistleblower who claimed that it was his skepticism about the utility of the drug that led to his firing. How could hydroxychloroquine be as dangerous as former top vaccine official Rick Bright suggested, Trump offered, given that he himself was using it?
The revelation quickly prompted reporters to ask what evidence Trump had that the drug was at all efficacious in addressing the virus and disease it causes, covid-19. Simple, Trump replied: Lots of people called him and said it worked.
“The only negative I’ve heard was the study where they gave it — was it the VA?” Trump said, referring to the Department of Veterans Affairs. “With, you know, people that aren’t big Trump fans gave it.” He then went on to express surprise at this perceived disloyalty from VA, given the legislation he had signed to support it. (The legislation he mentioned was in fact first signed by President Barack Obama.) Continue reading.